Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C16orf92 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-10 |
mRNA | N4BP2L1 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
mRNA | ZNF708 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-10 |
mRNA | CTD-2369P2.12 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
mRNA | ZNF713 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-09 |
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |